quarter. We are therefore keeping a close watch on the situation, while analyzing the course of events. Subject to our regular reviews and improvements in liquidity risk management processes at KBank and K
transparency. The new lending policy will be put in place within the end of next year. Furthermore, we communicated to stakeholders our experiences in the drive towards a Bank of Sustainability through the
Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2018 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and
Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2018 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and
Analysis (MD&A) Consolidated Financial Results: 3Q18 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 2 of 15
Pattana PCL Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2Q20 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s
Pattana PCL Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2Q20 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s
financial statements. 3.3 Rationale and background of the transaction Currently, the Company encounters the situation of the lack of financial liquidity and the cash flow for the business operation, as the
disclosed to the SET. 3.3 Rationale and background of the transaction Currently, the Company encounters the situation of the lack of financial liquidity and the cash flow for the debt repayment and the
Discussion and Analysis (MD&A) Consolidated Financial Results: 1Q20 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A